Antibacterial activity of chitosan nanofiber meshes with liposomes immobilized releasing gentamicin

Acta Biomaterialia
Nelson MonteiroNuno M Neves

Abstract

Chitsan (Ch) nanofiber mesh (NFM) is a material with natural characteristics favoring its use in human wound dressing. The present work proposes a gentamicin-loaded liposome immobilized at the surface of Ch NFMs to promote its antibacterial activity. To achieve this purpose, Ch NFMs were functionalized with thiol groups, and gentamicin-loaded liposomes were covalently immobilized by the reaction of the SH groups with maleimide. The maximum concentration of SH groups (55.52±11.19nmolcm(-2)) was obtained at pH 7. A fluorescent dye was covalently bound to the SH groups present at the surface of electrospun Ch NFMs. Their spatial distribution was uniform throughout the NFMs when analyzed by fluorescence microscopy. Gentamicin was successfully encapsulated into the liposomes with an efficiency of 17%. Gentamicin-loaded liposomes were uniformly distributed at the surface of the Ch NFMs and the drug release kinetic showed a sustained release of gentamicin during 16h, achieving a steady state at 24h. The in vitro susceptibility tests confirmed that the gentamicin released from the liposomes immobilized at the surface of electrospun Ch NFM has bactericidal activity against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aure...Continue Reading

References

Dec 1, 1979·Antimicrobial Agents and Chemotherapy·P Vaudaux, F A Waldvogel
Jan 1, 1980·Annual Review of Biophysics and Bioengineering·F Szoka, D Papahadjopoulos
Feb 17, 1999·Archives of Biochemistry and Biophysics·N RapoportA A Timoshin
Nov 21, 2000·International Journal of Pharmaceutics·P Frutos CabanillasG Frutos
Sep 5, 2001·The Journal of Antimicrobial Chemotherapy·R SchiffelersI Bakker-Woudenberg
Sep 5, 2002·Journal of Biomedical Materials Research·Yong Zhang, Miqin Zhang
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·Martin H EllbogenLaurel C Preheim
Apr 8, 2003·Current Protein & Peptide Science·V P Torchilin, T S Levchenko
Jul 5, 2003·International Journal of Pharmaceutics·Andreas Bernkop-SchnürchTheresa Zoidl
Nov 19, 2003·Advanced Drug Delivery Reviews·Zbigniew Ruszczak, Wolfgang Friess
Jan 20, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Andreas Bernkop-SchnürchDavide Guggi
Apr 30, 2004·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Abul Kalam AzadWillem Frans Stevens
Nov 18, 2005·International Journal of Pharmaceutics·Clement MugabeAbdelwahab Omri
Jul 19, 2006·Cellular & Molecular Biology Letters·Zuzanna Drulis-KawaArkadiusz Kozubek
Feb 14, 2007·Journal of Biomedical Materials Research. Part a·Laura M Y YuMolly S Shoichet
Oct 30, 2007·Journal of Pharmaceutical Sciences·Joshua S BoatengGillian M Eccleston
Dec 22, 2007·Nanomedicine·Albino MartinsNuno M Neves
May 20, 2008·International Journal of Pharmaceutics·Yimei JiaAbdelwahab Omri
Oct 17, 2009·Journal of Liposome Research·Yimei JiaAbdelwahab Omri
Nov 27, 2009·Journal of the Royal Society, Interface·Wiebke Ulbrich, Alf Lamprecht
Feb 4, 2010·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Jonathan J ElsnerMeital Zilberman
Aug 20, 2010·Journal of the Royal Society, Interface·Kangwon LeeDavid J Mooney
Sep 24, 2010·Journal of the Royal Society, Interface·Cassandra M Kelleher, Joseph P Vacanti
Apr 7, 2011·Burns : Journal of the International Society for Burn Injuries·Jonathan J ElsnerMeital Zilberman
Jul 20, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Catrin StrobelBritt Wildemann
Aug 4, 2011·Tissue Engineering. Part B, Reviews·Ana Rita Costa-PintoNuno M Neves
Mar 10, 2012·Biomacromolecules·Andrea MickovaEvzen Amler
Apr 24, 2012·Bioelectrochemistry·Eugenia KovácsMihaela-Georgeta Moisescu
Jul 11, 2012·Journal of Pharmaceutical Sciences·Julia HurlerNataša Skalko-Basnet
Oct 9, 2012·The Journal of Pathology·Brittan S Scales, Gary B Huffnagle
Oct 17, 2012·International Journal of Nanomedicine·Jakub SircJiri Michalek
Jan 1, 2011·International Journal of Pharmaceutical Investigation·Roonal L Jain, J P Shastri
Dec 4, 2012·International Journal of Biological Macromolecules·Jae-Min ParkYang-Hoon Kim
May 23, 2013·Journal of Materials Science. Materials in Medicine·Yang LiZhen-An Zhu

❮ Previous
Next ❯

Citations

Sep 11, 2016·Materials Science & Engineering. C, Materials for Biological Applications·Qiuyan LiGuo He
May 19, 2017·Nanomedicine·Shixuan ChenJingwei Xie
May 23, 2017·Therapeutic Delivery·Claudia Zylberberg, Sandro Matosevic
Feb 2, 2018·International Journal of Molecular Sciences·Saad B QasimIhtesham Ur Rehman
May 24, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gregor KravanjaMaja Leitgeb
Aug 23, 2019·Biomaterials Science·Young Ju SonHyuk Sang Yoo
Oct 21, 2019·Journal of Materials Science. Materials in Medicine·Shirin NourS Mohammad Moazzeni
Jun 21, 2017·Biofabrication·Yongliang ZhangChengtie Wu
Aug 22, 2020·Biomaterials Science·Thomas J HallSophie C Cox
Nov 30, 2018·Macromolecular Bioscience·Rahimeh RasouliAlain Dufresne
May 23, 2018·Journal of Functional Biomaterials·Wan Khartini Wan Abdul KhodirDeny Susanti
Sep 27, 2019·Current Pharmaceutical Design·Gitika A DhingraManju Nagpal
May 6, 2020·Marine Drugs·Tingting YanSidong Li
Dec 8, 2020·Biochemistry. Biokhimii︠a︡·I G ShemyakinI A Dyatlov
Feb 22, 2021·Drug Delivery and Translational Research·Pia KaiserMaike Windbergs
May 21, 2021·Biomaterials Science·Zejun XuJun Wu
Jun 8, 2018·Journal of Agricultural and Food Chemistry·Lingli DengHui Zhang
Aug 19, 2021·Macromolecular Bioscience·Fengze MiaoQuangang Zhu
Sep 23, 2021·Dalton Transactions : an International Journal of Inorganic Chemistry·Tetsuo YamaguchiJae-Min Oh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.